Why Engaging Regulators Early Made ReallyRecycle Stronger

Regulators aren’t there to be feared—they’re there to be understood.

Our conversations with the Medicines and Healthcare products Regulatory Agency and the Health and Safety Executive became one of the most valuable positioning exercises for ReallyRecycle.

If you’re operating anywhere near healthcare products or distributed manufacturing in the UK, you cannot avoid engaging with:

• Regulatory bodies
• Product safety law
• Real-world interpretation of compliance

A working understanding of the General Product Safety Regulations 2005 is not optional—it’s foundational.

Designing With Regulation, Not Around It

From the outset, we made a deliberate decision:

Don’t interpret regulation in isolation—test it directly with regulators.

This became critical when exploring a new question:
What happens when manufacturing is decentralised and crosses responsibility boundaries?

This is exactly the scenario ReallyRecycle introduces—where waste is transformed and products are manufactured locally, often within the same organisation that generated the material.

Traditional regulatory frameworks were not designed with this model in mind.

The conversations were not always straightforward—often taking weeks to arrange and requiring iteration—but they provided clarity that no documentation alone could.

Is It a Medical Device? Start There.

Before anything else, you must determine whether a product is a “medical device.”

This classification dictates:

• Whether a CE (now UKCA) marking is required
• The level of regulatory scrutiny
• The pathway to market

In ReallyRecycle’s case, there is a clear distinction:

• The platform itself (the circular manufacturing system) is not designed to protect patients
• The products produced by the platform may be

That distinction is critical—and it shapes how compliance is approached.

Why In-House Manufacturing Matters

A key regulatory insight came from how in-house manufacturing is treated.

Where products are:

• Manufactured within a healthcare institution
• Used within that same institution
• Not placed on the open market

…they fall outside typical commercial medical device placement rules.

This allows NHS organisations, for example, to:

• Design and produce solutions locally
• Deploy them internally
• Maintain control over safety and validation

This aligns directly with ReallyRecycle’s model:

• On-site circular microeconomy infrastructure
• Localised production from recovered materials
• Controlled, closed-loop manufacturing environments

COVID-19: A Temporary Shift in Regulation

During the COVID-19 pandemic, the Medicines and Healthcare products Regulatory Agency introduced emergency exemptions.

These allowed:

• Rapid production of essential equipment
• Community-led manufacturing efforts
• Deployment without full certification pathways

However, these exemptions were always temporary.

Any product created under these conditions still requires:

• A defined route to certification
• A transition into full regulatory compliance

For ReallyRecycle, this reinforced a critical principle:

Speed is valuable—but compliance is non-negotiable.

Building Safety as a First-Class System

Health and safety was never an afterthought—it was embedded from day one.

Early system validation included:

• Machine behaviour and failure modes
• Material performance and consistency
• Air quality, emissions, and filtration
• Energy usage and thermal risks
• Misuse scenarios and edge cases

Rather than relying on fragmented or anecdotal sources, we treated safety as a research discipline:

• Evidence-led
• Measured
• Context-specific

Because ultimately, safety is not about the product in isolation—but how it behaves in the real world.

The Real Value of Regulators

Engaging regulators early doesn’t slow innovation—it sharpens it.

It:

• Validates assumptions
• Identifies blind spots
• Prevents costly missteps later
• Provides confidence in system design

In our case, it did something simpler:

It confirmed that the model made sense.

Conclusion

Healthcare-adjacent innovation without regulatory alignment is fragile.

By working directly with bodies like the Medicines and Healthcare products Regulatory Agency and the Health and Safety Executive, ReallyRecycle has been able to:

• Define its position clearly
• Structure its model around compliance
• Build a platform that can operate safely within real-world constraints

Regulation isn’t a barrier.

It’s part of the system design.